Novel allogeneic CAR T cell therapy shows promising results in patients with metastatic clear cell renal cell carcinoma
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), ...
Apr 17, 2023
0
2